Anne Samuel
Stock Analyst at JP Morgan
(2.37)
# 2,403
Out of 4,842 analysts
66
Total ratings
50%
Success rate
-2.42%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $52.30 | +14.72% | 6 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $138.31 | +27.97% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $29.26 | +23.03% | 5 | Mar 20, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $218 → $249 | $276.16 | -9.83% | 6 | Mar 20, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $13 → $12 | $7.44 | +61.29% | 12 | Mar 10, 2025 | |
| PGNY Progyny | Maintains: Neutral | $17 → $23 | $21.40 | +7.48% | 7 | Jan 28, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $24.06 | +16.38% | 2 | Sep 9, 2024 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $22.89 | -16.99% | 4 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $21.86 | -3.93% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $3.55 | +266.20% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $38.73 | -30.29% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $3.24 | +54.56% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $86 → $108 | $101.01 | +6.92% | 8 | Apr 2, 2024 |
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $52.30
Upside: +14.72%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $138.31
Upside: +27.97%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $29.26
Upside: +23.03%
Veeva Systems
Mar 20, 2025
Maintains: Neutral
Price Target: $218 → $249
Current: $276.16
Upside: -9.83%
Evolent Health
Mar 10, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.44
Upside: +61.29%
Progyny
Jan 28, 2025
Maintains: Neutral
Price Target: $17 → $23
Current: $21.40
Upside: +7.48%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $24.06
Upside: +16.38%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $22.89
Upside: -16.99%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $21.86
Upside: -3.93%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $3.55
Upside: +266.20%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $38.73
Upside: -30.29%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $3.24
Upside: +54.56%
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $101.01
Upside: +6.92%